Compare Adaptive Biotechnologies Corp (ADPT) vs Ally Financial Inc (ALLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Ally Financial Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Ally Financial Inc trades at $44.15 (market cap $13.37B). The key difference: Ally Financial Inc is far larger — about 3.3× Adaptive Biotechnologies Corp's market cap, and Ally Financial Inc pays a 2.73% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | ALLY | |
|---|---|---|
Market Cap | $4.04B | $13.37B |
Sector | Health | Financials |
52-Week High | $25.45 | $47.25 |
52-Week Low | $12.30 | $35.96 |
Enterprise Value | $4.10B | — |
Dividend Yield | — | 2.73% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Ally Financial Inc
Ally Financial Inc is a diversified financial services firm that services automotive dealers and their retail customers. The company operates as a financial holding company and a bank holding company. Its banking subsidiary, Ally Bank, caters to the direct banking market through Internet, mobile, and mail. The company reports four business segments including Automotive Finance operations, Insurance operations, Mortgage Finance operations and Corporate Finance operations.
Read more on ALLY →
